Maimon Yossi

Vice President & CFOProtalix BioTherapeutics, Inc. (PLX) · full profile →Form 4 · filed Dec 15, 2015
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 14, 2015Buy(P)10K$0.78$8K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001144204-15-070834) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.